1. Home
  2. PTMN vs KRRO Comparison

PTMN vs KRRO Comparison

Compare PTMN & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTMN
  • KRRO
  • Stock Information
  • Founded
  • PTMN 2006
  • KRRO 2014
  • Country
  • PTMN United States
  • KRRO United States
  • Employees
  • PTMN N/A
  • KRRO 104
  • Industry
  • PTMN Finance: Consumer Services
  • KRRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PTMN Finance
  • KRRO Health Care
  • Exchange
  • PTMN Nasdaq
  • KRRO Nasdaq
  • Market Cap
  • PTMN 113.0M
  • KRRO 101.4M
  • IPO Year
  • PTMN N/A
  • KRRO 2019
  • Fundamental
  • Price
  • PTMN $11.77
  • KRRO $14.85
  • Analyst Decision
  • PTMN Hold
  • KRRO Strong Buy
  • Analyst Count
  • PTMN 1
  • KRRO 7
  • Target Price
  • PTMN $14.00
  • KRRO $85.67
  • AVG Volume (30 Days)
  • PTMN 47.8K
  • KRRO 197.2K
  • Earning Date
  • PTMN 05-08-2025
  • KRRO 05-07-2025
  • Dividend Yield
  • PTMN 20.38%
  • KRRO N/A
  • EPS Growth
  • PTMN N/A
  • KRRO N/A
  • EPS
  • PTMN N/A
  • KRRO N/A
  • Revenue
  • PTMN $58,024,000.00
  • KRRO $4,821,000.00
  • Revenue This Year
  • PTMN N/A
  • KRRO $65.08
  • Revenue Next Year
  • PTMN $12.20
  • KRRO N/A
  • P/E Ratio
  • PTMN N/A
  • KRRO N/A
  • Revenue Growth
  • PTMN N/A
  • KRRO N/A
  • 52 Week Low
  • PTMN $11.54
  • KRRO $10.29
  • 52 Week High
  • PTMN $19.95
  • KRRO $98.00
  • Technical
  • Relative Strength Index (RSI)
  • PTMN 39.22
  • KRRO 53.00
  • Support Level
  • PTMN $11.54
  • KRRO $11.50
  • Resistance Level
  • PTMN $12.84
  • KRRO $13.54
  • Average True Range (ATR)
  • PTMN 0.25
  • KRRO 1.55
  • MACD
  • PTMN -0.00
  • KRRO 0.25
  • Stochastic Oscillator
  • PTMN 27.38
  • KRRO 71.36

About PTMN Portman Ridge Finance Corporation

Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Share on Social Networks: